Literature DB >> 11152627

Overexpression of human amyloid precursor protein in Drosophila.

Y Yagi1, S Tomita, M Nakamura, T Suzuki.   

Abstract

Amyloid precursor protein (APP) is the precursor of the beta-amyloid peptide which is associated with Alzheimer's disease. The physiological function of APP is not well understood. We have established model system for the analysis of APP function in Drosophila. In neural cells, overexpressed human APP was transported to the synaptic terminal in a manner similar to its localization in human neurons, which suggested that the Drosophila protein transport system localizes human APP appropriately. Expression of APP in imaginal discs resulted in a defect in adult cuticle secretion and a blistered wing phenotype. The severity of the wing blister phenotype was proportional to the APP expression level. These results suggested the presence in Drosophila wing tissue of a protein or protein(s) which can interact with APP. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11152627     DOI: 10.1006/mcbr.2000.0248

Source DB:  PubMed          Journal:  Mol Cell Biol Res Commun        ISSN: 1522-4724


  5 in total

1.  Human APP gene expression in nerve cells of Drosophila melanogaster causes alteration of synaptoptagmin 1 mRNA level.

Authors:  S V Sarantseva; D I Rodin; A L Schwarzman
Journal:  Dokl Biochem Biophys       Date:  2012-03-15       Impact factor: 0.788

Review 2.  Transgenic Drosophila models of Alzheimer's disease and tauopathies.

Authors:  Kanae Iijima-Ando; Koichi Iijima
Journal:  Brain Struct Funct       Date:  2009-12-05       Impact factor: 3.270

3.  Overexpression of myocilin in the Drosophila eye activates the unfolded protein response: implications for glaucoma.

Authors:  Mary Anna Carbone; Julien F Ayroles; Akihiko Yamamoto; Tatiana V Morozova; Steven A West; Michael M Magwire; Trudy F C Mackay; Robert R H Anholt
Journal:  PLoS One       Date:  2009-01-16       Impact factor: 3.240

Review 4.  Drosophila melanogaster as a model organism for Alzheimer's disease.

Authors:  Katja Prüßing; Aaron Voigt; Jörg B Schulz
Journal:  Mol Neurodegener       Date:  2013-11-22       Impact factor: 14.195

Review 5.  Therapeutic opportunities of small interfering RNA.

Authors:  Bhoomika R Goyal; Mayur M Patel; Mithil K Soni; Shraddha V Bhadada
Journal:  Fundam Clin Pharmacol       Date:  2009-08       Impact factor: 2.748

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.